You are here

  • Home
  • Archive
  • Volume 66, Issue 8
  • The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS

Article metrics

Article menu
Download PDFPDF
Neurogastroenterology
Original article
The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS

 

Online download statistics by month:

Online download statistics by month: April 2016 to March 2024

AbstractFullPdf
Apr 20165981523
May 20162151816
Jun 20161461213
Jul 2016931011
Aug 201611258
Sep 2016891010
Oct 201668137
Nov 20169576
Dec 201648433
Jan 2017130106
Feb 201781143
Mar 2017613512
Apr 20174064
May 201749116
Jun 201765116
Jul 20174455836
Aug 20172454228
Sep 20171401917
Oct 20171662914
Nov 20171121511
Dec 20178844
Jan 2018114179
Feb 2018105176
Mar 2018131167
Apr 2018108126
May 2018180910
Jun 201810936
Jul 20186211
Aug 20184153
Sep 201885132
Oct 20184476
Nov 20187374
Dec 20183662
Jan 20197187
Feb 20196078
Mar 20196244
Apr 20193884
May 201967126
Jun 201933118
Jul 20193831
Aug 201929122
Sep 20193520
Oct 20192264
Nov 20193422
Dec 20196713
Jan 20207842
Feb 20204332
Mar 20204544
Apr 20204255
May 20209389
Jun 20203233
Jul 20208143
Aug 20202532
Sep 20205331
Oct 20204162
Nov 20206156
Dec 20203630
Jan 20214823
Feb 20217013
Mar 20211732
Apr 20212733
May 20211864
Jun 2021110
Jul 2021312
Aug 2021100
Sep 2021950
Oct 20213623
Nov 202115943
Dec 20219141
Jan 20228220
Feb 20225630
Mar 20225720
Apr 202211482
May 202217373
Jun 20227074
Jul 20226243
Aug 20227553
Sep 202297192
Oct 20226851
Nov 20228461
Dec 20222832
Jan 20234062
Feb 202310830
Mar 20233752
Apr 20233582
May 20234150
Jun 202312542
Jul 20233821
Aug 20233057
Sep 20235551
Oct 20234610
Nov 20235660
Dec 20237732
Jan 20248733
Feb 20243822
Mar 20244010
Total7659750493